<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant compared to the Control group, <sup>#</sup>P<0.05, statistically significant compared to the DM group (Bonferroni-adjusted pairwise comparison regarding the main group effect after two-way repeated measures ANOVA).</p
<p>Abbreviations: ANOVA, analysis of variance;</p><p><i>BDNF</i>, brain-derived neurotrophic factor;...
<p>The graphs show performance of Group I in the progressive ratio and FR5 control tests when rats w...
<p>*p = 0.028 Overall there is a significant difference between the treatment arms.</p><p>One way AN...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
Control, n = 28; HCD, n = 26; Control+ART, n = 27; HCD+ART, n = 32. ap vs. Control bp vs. Control+AR...
<p>In each trial, rats were classified as leaders or followers according to their performance in the...
<p>Neurological functional tests were performed in each group at each time point (n = 6), respective...
<p>(A) Rotation cycles of rats at detection points (n = 14–16). ‘Early’ represents the group receivi...
*<p><i>P</i><0.05 vs. Group E. Group A: SPA-DXM-NLP (1 mg/kg); Group B: SPA-DXM-NLP (0.5 mg/kg); Gro...
<p>The body weights (mean<i>±</i>SD) of each group of rats (n = 10 per group) recorded weekly are sh...
Mean ± SEM body weight of rats following injection of saline (CON; black; n = 6), monocrotaline (MCT...
<p>Values are means±SEM. In parenthesis are the number of rats. Factorial ANOVA with repeated measur...
<p>Results of two-way ANOVAs testing for effects of age and region on baseline measures of each depe...
<p>Abbreviations: ANOVA, analysis of variance;</p><p><i>BDNF</i>, brain-derived neurotrophic factor;...
<p>The graphs show performance of Group I in the progressive ratio and FR5 control tests when rats w...
<p>*p = 0.028 Overall there is a significant difference between the treatment arms.</p><p>One way AN...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
<p>Data are presented as means ± SEM for 8 rats in each group. **P<0.01, statistically significant c...
Control, n = 28; HCD, n = 26; Control+ART, n = 27; HCD+ART, n = 32. ap vs. Control bp vs. Control+AR...
<p>In each trial, rats were classified as leaders or followers according to their performance in the...
<p>Neurological functional tests were performed in each group at each time point (n = 6), respective...
<p>(A) Rotation cycles of rats at detection points (n = 14–16). ‘Early’ represents the group receivi...
*<p><i>P</i><0.05 vs. Group E. Group A: SPA-DXM-NLP (1 mg/kg); Group B: SPA-DXM-NLP (0.5 mg/kg); Gro...
<p>The body weights (mean<i>±</i>SD) of each group of rats (n = 10 per group) recorded weekly are sh...
Mean ± SEM body weight of rats following injection of saline (CON; black; n = 6), monocrotaline (MCT...
<p>Values are means±SEM. In parenthesis are the number of rats. Factorial ANOVA with repeated measur...
<p>Results of two-way ANOVAs testing for effects of age and region on baseline measures of each depe...
<p>Abbreviations: ANOVA, analysis of variance;</p><p><i>BDNF</i>, brain-derived neurotrophic factor;...
<p>The graphs show performance of Group I in the progressive ratio and FR5 control tests when rats w...
<p>*p = 0.028 Overall there is a significant difference between the treatment arms.</p><p>One way AN...